WO2001075021A3 - Nouveau polypeptide, proteine humaine associee au transport de glucose 10, et polynucleotide codant pour ce polypeptide - Google Patents
Nouveau polypeptide, proteine humaine associee au transport de glucose 10, et polynucleotide codant pour ce polypeptide Download PDFInfo
- Publication number
- WO2001075021A3 WO2001075021A3 PCT/CN2001/000359 CN0100359W WO0175021A3 WO 2001075021 A3 WO2001075021 A3 WO 2001075021A3 CN 0100359 W CN0100359 W CN 0100359W WO 0175021 A3 WO0175021 A3 WO 0175021A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- polynucleotide encoding
- human protein
- glucose transport
- discloses
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102000003839 Human Proteins Human genes 0.000 title abstract 3
- 108090000144 Human Proteins Proteins 0.000 title abstract 3
- 230000006377 glucose transport Effects 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010012559 Developmental delay Diseases 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000008152 organic acidemia Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
L'invention concerne un nouveau polypeptide, une protéine humaine associée au transport de glucose 10, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des troubles du métabolisme, de l'acidémie organique, de toutes sortes de tumeurs, des troubles du développement, des inflammations, des maladies immunitaires, de l'hémopathie et de l'infection par VIH. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine humaine associée au transport de glucose 10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU48239/01A AU4823901A (en) | 2000-03-22 | 2001-03-19 | A novel polypeptide, glucose transport-associated human protein 10 and the polynucleotide encoding the polypeptide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00115046 CN1314398A (zh) | 2000-03-22 | 2000-03-22 | 一种新的多肽——人葡萄糖转运相关蛋白10和编码这种多肽的多核苷酸 |
| CN00115046.4 | 2000-03-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001075021A2 WO2001075021A2 (fr) | 2001-10-11 |
| WO2001075021A3 true WO2001075021A3 (fr) | 2007-11-15 |
Family
ID=4584517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2001/000359 WO2001075021A2 (fr) | 2000-03-22 | 2001-03-19 | Nouveau polypeptide, proteine humaine associee au transport de glucose 10, et polynucleotide codant pour ce polypeptide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1314398A (fr) |
| AU (1) | AU4823901A (fr) |
| WO (1) | WO2001075021A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113557058A (zh) * | 2019-03-12 | 2021-10-26 | 通用电气公司 | 靶向葡萄糖转运子和/或肠促胰岛素途径的神经调节 |
-
2000
- 2000-03-22 CN CN 00115046 patent/CN1314398A/zh active Pending
-
2001
- 2001-03-19 WO PCT/CN2001/000359 patent/WO2001075021A2/fr active Application Filing
- 2001-03-19 AU AU48239/01A patent/AU4823901A/en not_active Abandoned
Non-Patent Citations (5)
| Title |
|---|
| DATABASE EMBL [online] 23 November 1999 (1999-11-23), XP003018864, Database accession no. (Z78022) * |
| DATABASE GENBANK [online] 1 April 1999 (1999-04-01), XP003018867, Database accession no. (AC006059) * |
| DATABASE GENBANK [online] 21 December 1999 (1999-12-21), SULSTON J.E. AND WILSON R.: "Toward a complete human genome sequence", XP003018865, Database accession no. (AC004911) * |
| DATABASE GENBANK [online] 21 December 1999 (1999-12-21), SULSTON J.E. AND WILSON R.: "Toward a complete human genome sequence", XP003018866, Database accession no. (AC006459) * |
| GENOME RES., vol. 8, no. 11, 1998, pages 1097 - 1108 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001075021A2 (fr) | 2001-10-11 |
| CN1314398A (zh) | 2001-09-26 |
| AU4823901A (en) | 2001-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001075021A3 (fr) | Nouveau polypeptide, proteine humaine associee au transport de glucose 10, et polynucleotide codant pour ce polypeptide | |
| WO2001083685A3 (fr) | Nouveau polypeptide, proteine cap 10, et polynucleotide codant pour ce polypeptide | |
| WO2001075036A3 (fr) | Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide | |
| WO2001079431A3 (fr) | Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide | |
| WO2001075016A3 (fr) | Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide | |
| WO2001075053A3 (fr) | Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide | |
| WO2002000821A3 (fr) | Nouveau polypeptide, proteine humaine plp 39, et polynucleotide codant ce polypeptide | |
| WO2001075011A3 (fr) | Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide | |
| WO2001083682A3 (fr) | Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide | |
| WO2001075048A3 (fr) | Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide | |
| WO2001075062A3 (fr) | Nouveau polypeptide, hydrogenase humaine 10, et polynucleotide codant pour ce polypeptide | |
| WO2001075015A3 (fr) | Nouveau polypeptide, fat24, et polynucleotide codant pour ce polypeptide | |
| WO2001079428A3 (fr) | Nouveau polypeptide, proteine humaine de reparation 8.9 du mesappariement de l'adn, et polynucleotide codant pour ce polypeptide | |
| WO2001075056A3 (fr) | Nouveau polypeptide, clathrine humaine a chaine legere 20, et polynucleotide codant pour ce polypeptide | |
| WO2001083681A3 (fr) | Nouveau polypeptide, dihydroorotase humaine 21, et polynucleotide codant pour ce polypeptide | |
| WO2001075029A3 (fr) | Nouveau polypeptide, facteur humain 11 associe a nf-e2, et polynucleotide codant pour ce polypeptide | |
| WO2001079439A3 (fr) | Nouveau polypeptide, proteine humaine de reception cannabinoide 19, et un polynucleotide codant pour ce polypeptide | |
| WO2002000823A3 (fr) | Nouveau polypeptide, proteine d'activation enzymatique ras gtp 9.57, et polynucleotide codant ce polypeptide | |
| WO2001075034A3 (fr) | Nouveau polypeptide, peroxydase proteine humaine 15, et polynucleotide codant pour ce polypeptide | |
| WO2001075035A3 (fr) | Nouveau polypeptide, peroxydase proteine humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2001075024A3 (fr) | Nouveau polypeptide, facteur humain 13 associe a nf-e2, et polynucleotide codant pour ce polypeptide | |
| WO2001075057A3 (fr) | Nouveau polypeptide, proteine ribosomale s4 humaine 12, et polynucleotide codant pour ce polypeptide | |
| WO2001094540A3 (fr) | Nouveau polypeptide, glycosyl hydrolase humaine 23, et polynucleotide codant ce polypeptide | |
| WO2001081538A3 (fr) | Nouveau polypeptide, connexine humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2001081536A3 (fr) | Nouveau polypeptide, proteine kinase ysk1 humaine 10, et polynucleotide codant pour ce polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |